Sirolimus Dosage during and after Conversion from Calcineurin Inhibitor Therapy to Sirolimus in Chronic Kidney Transplant Patients

Publisher： Karger

E-ISSN： 1423-0143|27|3|186-190

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.27, Iss.3, 2004-08, pp. : 186-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Late Calcineurin Inhibitor Withdrawal as a Strategy to Prevent Graft Loss in Patients with Suboptimal Kidney Transplant Function

By  

American Journal of Nephrology, Vol. 24, Iss. 4, 2004-09 ,pp. : 379-386

Karger

Access to resources Recommend Favorite

Induction Sirolimus and Delayed Graft Function after Deceased Donor Kidney Transplantation in the United States

By  

American Journal of Nephrology, Vol. 24, Iss. 4, 2004-09 ,pp. : 393-401

Karger

Access to resources Recommend Favorite

Prognosis of Dialysed Patients after Kidney Transplant Failure

By  

Kidney and Blood Pressure Research, Vol. 37, Iss. 2-3, 2013-05 ,pp. : 151-157

Karger

Access to resources Recommend Favorite

Low-Dose Sirolimus in Combination with Mycophenolate Mofetil Improves Kidney Graft Function Late after Renal Transplantation and Suggests Pharmacokinetic Interaction of Both Immunosuppressive Drugs

By  

Kidney and Blood Pressure Research, Vol. 27, Iss. 3, 2004-08 ,pp. : 181-185

Karger

Access to resources Recommend Favorite

Viral Hepatitis Infections in Chronic Kidney Disease Patients and Renal Transplant Recipients

By  

Kidney and Blood Pressure Research, Vol. 35, Iss. 6, 2012-06 ,pp. : 454-467

Karger

Access to resources Recommend Favorite